A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Zhou, Jing ^a   Cao, Jie ^b   Lu, Zheming ^a   Liu, Hongwei ^b   Deng, Dajun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; PROTEIN P16;

ADULT; AMPLICON; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EPITHELIUM DYSPLASIA; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; METHYLIGHT ASSAY; MOLECULAR CLONING; MOUTH CANCER; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN METHYLATION; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY; CELL TRANSFORMATION; CPG ISLAND; CYTOLOGY; DNA METHYLATION; EPITHELIUM CELL; GENETIC MARKER; GENETICS; METHODOLOGY; MOUTH MUCOSA; NEOPLASM; PATHOLOGY; PRECANCER; TUMOR SUPPRESSOR GENE;

CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; CPG ISLANDS; DNA METHYLATION; EPITHELIAL CELLS; GENES, P16; GENETIC MARKERS; HUMANS; MOUTH MUCOSA; NEOPLASMS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 79955848434     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-67     Document Type: Article

References (20)

1. Deng D, Liu Z, Du Y. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Adv Genet 2010, 71:125-176.
2. Wong DJ, Foster SA, Galloway DA, Reid BJ. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol 1999, 19:5642-5651. 84416, 10409753.
3. Luo DY, Zhang BZ, Lv LB, Xiang SY, Liu YH, Ji JF, Deng DJ. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Laboratory Investigation 2006, 86:591-598.
4. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet 2009, 18:3098-3109. 10.1093/hmg/ddp251, 19477956.
5. Capel E, Fléjou JF, Hamelin R. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis. Oncogene 2007, 26:7596-7600. 10.1038/sj.onc.1210581, 17546041.
6. Serrano M, Hannon G, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707. 10.1038/366704a0, 8259215.
7. Sun Y, Deng DJ, You WC, Bai H, Zhang L, Zhou J, Shen L, Ma JL, Xie YQ, Li JY. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clinical Cancer Research 2004, 10:5087-5093. 10.1158/1078-0432.CCR-03-0622, 15297411.
8. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kenned TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Research 2006, 66:3338-3344. 10.1158/0008-5472.CAN-05-3408, 16540689.
9. Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 2005, 24:4138-4148.
10. Wang JS, Guo M, Montgomery EA, Thompson RE, Cosby H, Hicks L, Wang S, Herman JG, Canto MI. DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus. Am J Gastroenterol 2009, 104:2153-2160. 10.1038/ajg.2009.300, 3090447, 19584833.
11. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru A, Paun B, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 2009, 69:4112-4115. 2752375, 19435894.
12. Hall G, Shaw R, Field E, Rogers S, Sutton D, Woolgar J, Lowe D, Liloglou T, Field J, Risk J. p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 2008, 17:2174-2179. 10.1158/1055-9965.EPI-07-2867, 18708411.
13. Cao J, Zhou J, Gao Y, Gu LK, Meng HX, Liu HW, Deng DJ. Methylation of p16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia: A Prospective Cohort Study. Clinical Cancer Research 2009, 15:5178-5183. 10.1158/1078-0432.CCR-09-0580, 19671846.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9821-9826. 10.1073/pnas.93.18.9821, 38513, 8790415.
15. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000, 60:5021-5026.
16. Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res 2006, 34:e78. 10.1093/nar/gkl424, 1904102, 16807314.
17. Widschwendter M, Siegmund KD, Müller HM, Fiegl H, Marth C, Müller-Holzner E, Jones PA, Laird PW. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 2004, 64:3807-3813. 10.1158/0008-5472.CAN-03-3852, 15172987.
18. Dieffenbach CW, Dveksler GS. PCR Primer: A Laboratory Manual. 1995, New York: Cold Spring Harbor Laboratory Press, 1.
19. Furihata C, Yamawaki Y, Jin SS, Moriya H, Kodama K, Matsushima T, Ishikawa T, Takayama S, Nakadate M. Induction of unscheduled DNA synthesis in rat stomach mucosa by glandular stomach carcinogens. J Natl Cancer Inst 1984, 72:1327-1334.
20. Tetzner R, Dietrich D, Distler J. Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA. Nucleic Acids Res 2007, 35:e4. 1747185, 17135186.